ID   ABI3_HUMAN              Reviewed;         366 AA.
AC   Q9P2A4; C9IZN8; Q9H0P6;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   18-JUN-2025, entry version 186.
DE   RecName: Full=ABI gene family member 3;
DE   AltName: Full=New molecule including SH3;
DE            Short=Nesh;
GN   Name=ABI3; Synonyms=NESH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANT
RP   SER-209.
RC   TISSUE=Placenta;
RX   PubMed=10978530; DOI=10.1016/s0167-4781(00)00158-5;
RA   Miyazaki K., Matsuda S., Ichigotani Y., Takenouchi Y., Hayashi K.,
RA   Fukuda Y., Nimura Y., Hamaguchi M.;
RT   "Isolation and characterization of a novel human gene (NESH) which encodes
RT   a putative signaling molecule similar to e3B1 protein.";
RL   Biochim. Biophys. Acta 1493:237-241(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS GLN-44 AND
RP   SER-209.
RC   TISSUE=Kidney;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-209.
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=11956071;
RA   Ichigotani Y., Yokozaki S., Fukuda Y., Hamaguchi M., Matsuda S.;
RT   "Forced expression of NESH suppresses motility and metastatic dissemination
RT   of malignant cells.";
RL   Cancer Res. 62:2215-2219(2002).
RN   [6]
RP   INTERACTION WITH TARSH.
RX   PubMed=11501947; DOI=10.1007/s100380170049;
RA   Matsuda S., Iriyama C., Yokozaki S., Ichigotani Y., Shirafuji N.,
RA   Yamaki K., Hayakawa T., Hamaguchi M.;
RT   "Cloning and sequencing of a novel human gene that encodes a putative
RT   target protein of Nesh-SH3.";
RL   J. Hum. Genet. 46:483-486(2001).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-213; SER-216 AND SER-342,
RP   VARIANT [LARGE SCALE ANALYSIS] SER-209, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May inhibit tumor metastasis (By similarity). In vitro,
CC       reduces cell motility. {ECO:0000250, ECO:0000269|PubMed:11956071}.
CC   -!- SUBUNIT: May interact with PAK1 and PAK2. Probably interacts with
CC       TARSH. {ECO:0000269|PubMed:11501947}.
CC   -!- INTERACTION:
CC       Q9P2A4; Q9NYB9-2: ABI2; NbExp=5; IntAct=EBI-742038, EBI-11096309;
CC       Q9P2A4; Q9P2A4: ABI3; NbExp=4; IntAct=EBI-742038, EBI-742038;
CC       Q9P2A4; Q9BRR9: ARHGAP9; NbExp=3; IntAct=EBI-742038, EBI-750254;
CC       Q9P2A4; Q9H6L4: ARMC7; NbExp=3; IntAct=EBI-742038, EBI-742909;
CC       Q9P2A4; Q13515: BFSP2; NbExp=5; IntAct=EBI-742038, EBI-10229433;
CC       Q9P2A4; Q8TDH9: BLOC1S5; NbExp=3; IntAct=EBI-742038, EBI-465861;
CC       Q9P2A4; Q7L2Z9: CENPQ; NbExp=3; IntAct=EBI-742038, EBI-2350265;
CC       Q9P2A4; Q9C0F1: CEP44; NbExp=9; IntAct=EBI-742038, EBI-744115;
CC       Q9P2A4; Q6ICB0: DESI1; NbExp=3; IntAct=EBI-742038, EBI-2806959;
CC       Q9P2A4; O60941: DTNB; NbExp=3; IntAct=EBI-742038, EBI-740402;
CC       Q9P2A4; O15372: EIF3H; NbExp=6; IntAct=EBI-742038, EBI-709735;
CC       Q9P2A4; Q7L2H7: EIF3M; NbExp=3; IntAct=EBI-742038, EBI-353901;
CC       Q9P2A4; Q6IB98: EIF3S3; NbExp=3; IntAct=EBI-742038, EBI-10184995;
CC       Q9P2A4; Q9Y6C2-2: EMILIN1; NbExp=3; IntAct=EBI-742038, EBI-11748557;
CC       Q9P2A4; Q9UI08: EVL; NbExp=4; IntAct=EBI-742038, EBI-346653;
CC       Q9P2A4; Q9UI08-2: EVL; NbExp=3; IntAct=EBI-742038, EBI-6448852;
CC       Q9P2A4; Q9H5Z6-2: FAM124B; NbExp=3; IntAct=EBI-742038, EBI-11986315;
CC       Q9P2A4; Q9Y285: FARSA; NbExp=3; IntAct=EBI-742038, EBI-725361;
CC       Q9P2A4; Q8TES7-6: FBF1; NbExp=3; IntAct=EBI-742038, EBI-10244131;
CC       Q9P2A4; Q9P2W3: GNG13; NbExp=3; IntAct=EBI-742038, EBI-11427343;
CC       Q9P2A4; Q8NBJ4: GOLM1; NbExp=3; IntAct=EBI-742038, EBI-712073;
CC       Q9P2A4; P62993: GRB2; NbExp=3; IntAct=EBI-742038, EBI-401755;
CC       Q9P2A4; Q86YM7: HOMER1; NbExp=4; IntAct=EBI-742038, EBI-746815;
CC       Q9P2A4; Q9NSB8-2: HOMER2; NbExp=3; IntAct=EBI-742038, EBI-12017090;
CC       Q9P2A4; Q9NSC5: HOMER3; NbExp=8; IntAct=EBI-742038, EBI-748420;
CC       Q9P2A4; Q8IY31-3: IFT20; NbExp=3; IntAct=EBI-742038, EBI-9091197;
CC       Q9P2A4; Q8IYA8: IHO1; NbExp=3; IntAct=EBI-742038, EBI-8638439;
CC       Q9P2A4; Q63ZY3: KANK2; NbExp=6; IntAct=EBI-742038, EBI-2556193;
CC       Q9P2A4; Q6ZU52: KIAA0408; NbExp=4; IntAct=EBI-742038, EBI-739493;
CC       Q9P2A4; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-742038, EBI-14069005;
CC       Q9P2A4; Q6P597: KLC3; NbExp=3; IntAct=EBI-742038, EBI-1643885;
CC       Q9P2A4; Q9NSK0: KLC4; NbExp=3; IntAct=EBI-742038, EBI-949319;
CC       Q9P2A4; A1A4E9: KRT13; NbExp=3; IntAct=EBI-742038, EBI-10171552;
CC       Q9P2A4; P02533: KRT14; NbExp=3; IntAct=EBI-742038, EBI-702178;
CC       Q9P2A4; Q2M2I5: KRT24; NbExp=3; IntAct=EBI-742038, EBI-2952736;
CC       Q9P2A4; Q7Z3Y7: KRT28; NbExp=3; IntAct=EBI-742038, EBI-11980489;
CC       Q9P2A4; Q15323: KRT31; NbExp=3; IntAct=EBI-742038, EBI-948001;
CC       Q9P2A4; Q92764: KRT35; NbExp=3; IntAct=EBI-742038, EBI-1058674;
CC       Q9P2A4; O76013-2: KRT36; NbExp=3; IntAct=EBI-742038, EBI-11958506;
CC       Q9P2A4; O76015: KRT38; NbExp=3; IntAct=EBI-742038, EBI-1047263;
CC       Q9P2A4; P43365: MAGEA12; NbExp=3; IntAct=EBI-742038, EBI-749530;
CC       Q9P2A4; Q9NX70: MED29; NbExp=3; IntAct=EBI-742038, EBI-394656;
CC       Q9P2A4; Q9NYP9: MIS18A; NbExp=3; IntAct=EBI-742038, EBI-1104552;
CC       Q9P2A4; Q9Y605: MRFAP1; NbExp=3; IntAct=EBI-742038, EBI-995714;
CC       Q9P2A4; Q96HT8: MRFAP1L1; NbExp=3; IntAct=EBI-742038, EBI-748896;
CC       Q9P2A4; O43639: NCK2; NbExp=6; IntAct=EBI-742038, EBI-713635;
CC       Q9P2A4; Q9GZM8: NDEL1; NbExp=3; IntAct=EBI-742038, EBI-928842;
CC       Q9P2A4; Q5HYW2: NHSL2; NbExp=3; IntAct=EBI-742038, EBI-2859639;
CC       Q9P2A4; Q9BVL2: NUP58; NbExp=7; IntAct=EBI-742038, EBI-2811583;
CC       Q9P2A4; O43482: OIP5; NbExp=3; IntAct=EBI-742038, EBI-536879;
CC       Q9P2A4; P25786: PSMA1; NbExp=3; IntAct=EBI-742038, EBI-359352;
CC       Q9P2A4; Q7L099: RUFY3; NbExp=3; IntAct=EBI-742038, EBI-722392;
CC       Q9P2A4; Q06455-2: RUNX1T1; NbExp=3; IntAct=EBI-742038, EBI-11984663;
CC       Q9P2A4; Q06455-4: RUNX1T1; NbExp=3; IntAct=EBI-742038, EBI-10224192;
CC       Q9P2A4; Q9Y3L3: SH3BP1; NbExp=3; IntAct=EBI-742038, EBI-346869;
CC       Q9P2A4; Q96GM5: SMARCD1; NbExp=3; IntAct=EBI-742038, EBI-358489;
CC       Q9P2A4; Q16623: STX1A; NbExp=3; IntAct=EBI-742038, EBI-712466;
CC       Q9P2A4; P32856-2: STX2; NbExp=3; IntAct=EBI-742038, EBI-11956649;
CC       Q9P2A4; Q9UMX1: SUFU; NbExp=3; IntAct=EBI-742038, EBI-740595;
CC       Q9P2A4; Q9BUZ4: TRAF4; NbExp=3; IntAct=EBI-742038, EBI-3650647;
CC       Q9P2A4; Q99757: TXN2; NbExp=3; IntAct=EBI-742038, EBI-2932492;
CC       Q9P2A4; Q5ST30: VARS2; NbExp=3; IntAct=EBI-742038, EBI-2116622;
CC       Q9P2A4; P50552: VASP; NbExp=9; IntAct=EBI-742038, EBI-748201;
CC       Q9P2A4; P42768: WAS; NbExp=4; IntAct=EBI-742038, EBI-346375;
CC       Q9P2A4; Q92558: WASF1; NbExp=3; IntAct=EBI-742038, EBI-1548747;
CC       Q9P2A4; B2R8Y4; NbExp=3; IntAct=EBI-742038, EBI-10175581;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11956071}.
CC       Note=Colocalizes with PAK2 at leading edge of cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9P2A4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P2A4-2; Sequence=VSP_041467;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, lung, liver, pancreas, kidney,
CC       placenta and at low levels in brain and skeletal muscle.
CC       {ECO:0000269|PubMed:10978530}.
CC   -!- SIMILARITY: Belongs to the ABI family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB037886; BAA90667.1; -; mRNA.
DR   EMBL; AL136709; CAB66644.1; -; mRNA.
DR   EMBL; AC004797; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069454; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007780; AAH07780.1; -; mRNA.
DR   CCDS; CCDS11546.1; -. [Q9P2A4-1]
DR   CCDS; CCDS45725.1; -. [Q9P2A4-2]
DR   RefSeq; NP_001128658.2; NM_001135186.2. [Q9P2A4-2]
DR   RefSeq; NP_057512.2; NM_016428.3. [Q9P2A4-1]
DR   AlphaFoldDB; Q9P2A4; -.
DR   SMR; Q9P2A4; -.
DR   BioGRID; 119389; 91.
DR   CORUM; Q9P2A4; -.
DR   FunCoup; Q9P2A4; 63.
DR   IntAct; Q9P2A4; 75.
DR   MINT; Q9P2A4; -.
DR   STRING; 9606.ENSP00000225941; -.
DR   GlyGen; Q9P2A4; 1 site.
DR   iPTMnet; Q9P2A4; -.
DR   PhosphoSitePlus; Q9P2A4; -.
DR   BioMuta; ABI3; -.
DR   DMDM; 296434384; -.
DR   jPOST; Q9P2A4; -.
DR   MassIVE; Q9P2A4; -.
DR   PaxDb; 9606-ENSP00000225941; -.
DR   PeptideAtlas; Q9P2A4; -.
DR   ProteomicsDB; 83763; -. [Q9P2A4-1]
DR   ProteomicsDB; 83764; -. [Q9P2A4-2]
DR   Antibodypedia; 53503; 90 antibodies from 22 providers.
DR   DNASU; 51225; -.
DR   Ensembl; ENST00000225941.6; ENSP00000225941.1; ENSG00000108798.9. [Q9P2A4-1]
DR   Ensembl; ENST00000419580.6; ENSP00000406651.2; ENSG00000108798.9. [Q9P2A4-2]
DR   GeneID; 51225; -.
DR   KEGG; hsa:51225; -.
DR   MANE-Select; ENST00000225941.6; ENSP00000225941.1; NM_016428.3; NP_057512.2.
DR   UCSC; uc002iop.1; human. [Q9P2A4-1]
DR   AGR; HGNC:29859; -.
DR   CTD; 51225; -.
DR   DisGeNET; 51225; -.
DR   GeneCards; ABI3; -.
DR   HGNC; HGNC:29859; ABI3.
DR   HPA; ENSG00000108798; Tissue enhanced (lymphoid).
DR   MIM; 606363; gene.
DR   NIAGADS; ENSG00000108798; -.
DR   OpenTargets; ENSG00000108798; -.
DR   VEuPathDB; HostDB:ENSG00000108798; -.
DR   eggNOG; KOG2546; Eukaryota.
DR   GeneTree; ENSGT00940000161380; -.
DR   HOGENOM; CLU_035421_0_0_1; -.
DR   InParanoid; Q9P2A4; -.
DR   OMA; NVAYHIQ; -.
DR   OrthoDB; 5971719at2759; -.
DR   PAN-GO; Q9P2A4; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9P2A4; -.
DR   PathwayCommons; Q9P2A4; -.
DR   SignaLink; Q9P2A4; -.
DR   SIGNOR; Q9P2A4; -.
DR   BioGRID-ORCS; 51225; 8 hits in 1135 CRISPR screens.
DR   ChiTaRS; ABI3; human.
DR   GeneWiki; ABI3; -.
DR   GenomeRNAi; 51225; -.
DR   Pharos; Q9P2A4; Tbio.
DR   PRO; PR:Q9P2A4; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9P2A4; protein.
DR   Bgee; ENSG00000108798; Expressed in granulocyte and 137 other cell types or tissues.
DR   ExpressionAtlas; Q9P2A4; baseline and differential.
DR   GO; GO:0098858; C:actin-based cell projection; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0043198; C:dendritic shaft; ISS:ARUK-UCL.
DR   GO; GO:0043197; C:dendritic spine; ISS:ARUK-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0030027; C:lamellipodium; IDA:MGI.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; ISS:ARUK-UCL.
DR   GO; GO:0031209; C:SCAR complex; IDA:ARUK-UCL.
DR   GO; GO:0051015; F:actin filament binding; ISS:ARUK-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0035591; F:signaling adaptor activity; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISS:ARUK-UCL.
DR   GO; GO:0048858; P:cell projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0002357; P:defense response to tumor cell; IMP:ARUK-UCL.
DR   GO; GO:0098885; P:modification of postsynaptic actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0010593; P:negative regulation of lamellipodium assembly; ISS:ARUK-UCL.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; ISS:ARUK-UCL.
DR   GO; GO:1900028; P:negative regulation of ruffle assembly; NAS:ARUK-UCL.
DR   GO; GO:0001764; P:neuron migration; IBA:GO_Central.
DR   GO; GO:2000774; P:positive regulation of cellular senescence; IMP:ARUK-UCL.
DR   GO; GO:0030334; P:regulation of cell migration; IDA:MGI.
DR   GO; GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:ARUK-UCL.
DR   GO; GO:0099151; P:regulation of postsynaptic density assembly; ISS:ARUK-UCL.
DR   CDD; cd11826; SH3_Abi; 1.
DR   FunFam; 2.30.30.40:FF:000170; ABI gene family member 3; 1.
DR   Gene3D; 6.10.140.1620; -; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028455; ABI3_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR10460:SF7; ABI GENE FAMILY MEMBER 3; 1.
DR   PANTHER; PTHR10460; ABL INTERACTOR FAMILY MEMBER; 1.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   neXtProt; NX_Q9P2A4; -.
DR   PharmGKB; PA134951642; -.
DR   TreeFam; TF314303; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Phosphoprotein;
KW   Proteomics identification; Reference proteome; SH3 domain.
FT   CHAIN           1..366
FT                   /note="ABI gene family member 3"
FT                   /id="PRO_0000191792"
FT   DOMAIN          308..366
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          161..195
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          215..302
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          33..61
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        232..248
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         342
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         90..95
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_041467"
FT   VARIANT         44
FT                   /note="R -> Q (in dbSNP:rs2233369)"
FT                   /evidence="ECO:0000269|PubMed:11230166"
FT                   /id="VAR_022030"
FT   VARIANT         203
FT                   /note="S -> F (in dbSNP:rs616338)"
FT                   /id="VAR_060243"
FT   VARIANT         209
FT                   /note="F -> S (in dbSNP:rs616338)"
FT                   /evidence="ECO:0000269|PubMed:10978530,
FT                   ECO:0000269|PubMed:11230166, ECO:0000269|PubMed:15489334,
FT                   ECO:0007744|PubMed:24275569"
FT                   /id="VAR_060993"
SQ   SEQUENCE   366 AA;  39035 MW;  23EC3838E41D8ECD CRC64;
     MAELQQLQEF EIPTGREALR GNHSALLRVA DYCEDNYVQA TDKRKALEET MAFTTQALAS
     VAYQVGNLAG HTLRMLDLQG AALRQVEARV STLGQMVNMH MEKVARREIG TLATVQRLPP
     GQKVIAPENL PPLTPYCRRP LNFGCLDDIG HGIKDLSTQL SRTGTLSRKS IKAPATPASA
     TLGRPPRIPE PVHLPVVPDG RLSAASSAFS LASAGSAEGV GGAPTPKGQA APPAPPLPSS
     LDPPPPPAAV EVFQRPPTLE ELSPPPPDEE LPLPLDLPPP PPLDGDELGL PPPPPGFGPD
     EPSWVPASYL EKVVTLYPYT SQKDNELSFS EGTVICVTRR YSDGWCEGVS SEGTGFFPGN
     YVEPSC
//
